Correlation Between Kronos Bio and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Atea Pharmaceuticals, you can compare the effects of market volatilities on Kronos Bio and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Atea Pharmaceuticals.
Diversification Opportunities for Kronos Bio and Atea Pharmaceuticals
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kronos and Atea is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Kronos Bio i.e., Kronos Bio and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kronos Bio and Atea Pharmaceuticals
Given the investment horizon of 90 days Kronos Bio is expected to generate 1.1 times more return on investment than Atea Pharmaceuticals. However, Kronos Bio is 1.1 times more volatile than Atea Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about -0.24 per unit of risk. If you would invest 97.00 in Kronos Bio on November 6, 2024 and sell it today you would earn a total of 4.00 from holding Kronos Bio or generate 4.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kronos Bio vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Kronos Bio |
| Atea Pharmaceuticals |
Kronos Bio and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kronos Bio and Atea Pharmaceuticals
The main advantage of trading using opposite Kronos Bio and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Kronos Bio vs. Cyclerion Therapeutics | Kronos Bio vs. Larimar Therapeutics | Kronos Bio vs. Addex Therapeutics | Kronos Bio vs. Achilles Therapeutics PLC |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |